Q2 2026 13F filing
Updated 28 days ago47 disclosed positions worth $1.1B
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TRVI Trevi Therapeutics Inc | $95M | 5.09M | 8.68% | — |
| 2 | P PRAX Praxis Precision Medicines | $90.8M | 271.1K | 8.29% | — |
| 3 | E EQR Erasca Inc | $75.6M | 4.13M | 6.90% | — |
| 4 | ? N/A Arrivent BioPharma Inc | $58.4M | 1.68M | 5.34% | — |
| 5 | A AAVXF Abivax SA - ADR | $55.3M | 414.9K | 5.05% | — |
| 6 | T TNGX Tango Therapeutics Inc | $43.1M | 1.38M | 3.94% | — |
| 7 | C CRVS Corvus Pharmaceuticals Inc | $41.9M | 2.81M | 3.83% | — |
| 8 | D DRUG Bright Minds Biosciences Inc | $39.1M | 557.2K | 3.57% | — |
| 9 | S SVA Sinovac Biotech Ltd. | $38.2M | 5.90M | 3.49% | — |
| 10 | ? N/A Tenax Therapeutics Inc | $36.4M | 2.50M | 3.32% | — |
| 11 | A ACRS Aclaris Therapeutics, Inc. | $35.4M | 6.69M | 3.23% | — |
| 12 | D DYN Dyne Therapeutics Inc | $34.6M | 1.56M | 3.16% | — |
| 13 | D DNTH Dianthus Therapeutics Inc | $34.5M | 354.0K | 3.15% | — |
| 14 | A ANRO Alto Neuroscience Inc | $31.9M | 1.21M | 2.91% | — |
| 15 | D DBVTF DBV Technologies SA | $30.3M | 1.84M | 2.76% | — |
| 16 | S SABSW SAB Biotherapeutics Inc | $28.5M | 7.30M | 2.60% | — |
| 17 | M MLTX Moonlake Immunotherapeutics | $27.3M | 1.40M | 2.49% | — |
| 18 | L LBRX LB Pharmaceuticals Inc | $26M | 800.0K | 2.37% | — |
| 19 | N NERV Minerva Neurosciences Inc | $24M | 4.32M | 2.19% | — |
| 20 | D DSGN Design Therapeutics Inc | $23.3M | 1.61M | 2.13% | — |
| 21 | O ORIC Oric Pharmaceuticals Inc | $20M | 1.85M | 1.83% | — |
| 22 | C CAMP CAMP4 Therapeutics Corporation | $18.6M | 4.25M | 1.69% | — |
| 23 | F FTH Faeth Therapeutics Inc | $18.1M | 722.0K | 1.65% | — |
| 24 | A ACHV Achieve Life Sciences Inc. | $18M | 2.75M | 1.64% | — |
| 25 | ? N/A Compass Therapeutics Inc | $17M | 7.76M | 1.55% | — |
| 26 | ? N/A AN2 Therapeutics Inc | $15.3M | 3.15M | 1.39% | — |
| 27 | E EIX Editas Medicine Inc | $11.5M | 3.56M | 1.05% | — |
| 28 | G GERN Geron Corp | $11.1M | 8.67M | 1.01% | — |
| 29 | O ODTX Odyssey Therapeutics Inc | $10.8M | 575.0K | 0.98% | — |
| 30 | E EPRX Eupraxia Pharmaceuticals Inc | $8.9M | 1.35M | 0.81% | — |
| 31 | O OKUR Onkure Therapeutics Inc | $8.8M | 1.93M | 0.80% | — |
| 32 | O OLMA Olema Pharmaceuticals Inc | $8.4M | 671.8K | 0.77% | — |
| 33 | M MNPR Monopar Therapeutics Inc | $8.4M | 90.5K | 0.77% | — |
| 34 | A AURA Aura Biosciences Inc | $8.3M | 1.17M | 0.76% | — |
| 35 | ? N/A Surrozen Inc | $6.7M | 260.0K | 0.62% | — |
| 36 | A ALXO ALX Oncology Holdings Inc | $6.6M | 3.18M | 0.60% | — |
| 37 | M MSLE Satellos Bioscience Inc | $6.3M | 813.7K | 0.58% | — |
| 38 | A AVTX Avalo Therapeutics Inc | $5.1M | 275.0K | 0.46% | — |
| 39 | P PEPG Pepgen Inc | $4.2M | 2.33M | 0.38% | — |
| 40 | V VALN Valneva SE | $4M | 763.2K | 0.36% | — |
| 41 | S SERA Sera Prognostics Inc | $3M | 1.65M | 0.27% | — |
| 42 | ? N/A Unicycive Therapeutics | $2.6M | 550.0K | 0.24% | — |
| 43 | T TIL Instil Bio Inc | $2.3M | 292.7K | 0.21% | — |
| 44 | I INM InMed Pharmaceuticals Inc | $1.2M | 798.4K | 0.11% | — |
| 45 | ? N/A Bolt Biotherapeutics Inc | $279K | 72.4K | 0.03% | — |
| 46 | K KTTAW Pasithea Therapeutics Corp | $240K | 465.5K | 0.02% | — |
| 47 | D DTIL Precision Biosciences Inc | $37K | 4.7K | 0.00% | — |